肠道菌群的改变对脓毒血症预后的影响

注册号:

Registration number:

ChiCTR-CPC-16008143 

最近更新日期:

Date of Last Refreshed on:

2016-03-22 20:30:56 

注册时间:

Date of Registration:

2016-03-22 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

肠道菌群的改变对脓毒血症预后的影响

Public title:

The effect of gut microbiota on the prognosis of Sepsis

注册题目简写:

English Acronym:

研究课题的正式科学名称:

肠道菌群的改变对脓毒血症预后的影响

Scientific title:

The effect of gut microbiota on the prognosis of Sepsis

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

邓力 

研究负责人:

邓力 

Applicant:

Li Deng 

Study leader:

Li Deng 

申请注册联系人电话:

Applicant telephone:

+86 18819351723

研究负责人电话:

Study leader's
telephone:

+86 18819351723

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

dengli@stu2015.jnu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

dengli@stu2015.jnu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市天河区黄埔大道西601号

研究负责人通讯地址:

广东省广州市天河区黄埔大道西601号

Applicant address:

601 West Huangpu Avenue, Guangzhou, China

Study leader's address:

601 West Huangpu Avenue, Guangzhou, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

暨南大学

Applicant's institution:

Jinan university

研究负责人所在单位:

暨南大学

Affiliation of the Leader:

Jinan university

是否获伦理委员会批准:

Approved by ethic committee:

No

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

暨南大学

Primary sponsor:

Jinan university

研究实施负责(组长)单位地址:

广东省广州市天河区黄埔大道西601号

Primary sponsor's address:

601 West Huangpu Avenue, Guangzhou, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东省

市(区县):

广州市

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

暨南大学

具体地址:

广州市天河区黄埔大道西601号

Institution
hospital:

Jinan university

Address:

601 West Huangpu Avenue, Guangzhou, China

国家:

中国

省(直辖市):

广东省

市(区县):

广州市

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广州中医院大学大学城医院

具体地址:

广州市番禺区大学城内环西路55号

Institution
hospital:

Guangdong Provincial Hospital of Traditional Chinese Medicine, university city Branch

Address:

55 West Inner Ring Road, University City, Panyu District, Guangzhou, Guangdong, China

经费或物资来源:

国家自然基金

Source(s) of funding:

National Nature Science Foundation of China

研究疾病:

脓毒症  

Target disease:

Sepsis

研究疾病代码:

Target disease code:

研究类型:

病因学/相关因素研究

Study type:

Cause/Relative factors study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

本研究通过16s检测肠道菌群,相关生化指标的改变,血液细菌培养。比较有胃肠道症状脓毒血症患者和无胃肠道症状的脓毒血症患者的肠道菌群的区别。从而揭示肠道菌群的改变对脓毒血症预后的影响。  

Objectives of Study:

The aims of this study is to determine the effect of gut microbiota on the prognosis of Sepsis, by using 16s pyrosequencing, comparing the blood culture result.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.拒绝参加本研究;2,主治医生或研究者认为存在其他不宜参加本研究的情况【需记录原因】。

Exclusion criteria:

1. Refuse to join;
2. Other reasons that are considered unsuitable for participation by the responsible surgeons or investigators (reasons must be recorded in the case report form).

研究实施时间:

Study execute time:

From 2016-04-15 00:00:00 To 2016-07-15 00:00:00  

征募观察对象时间:

Recruiting time:

From 2016-04-15 00:00:00 To 2016-07-15 00:00:00

干预措施:

Interventions:

组别:

有胃肠道症状脓毒症组

样本量:

20

Group:

Sepsis without Diarrhea

Sample size:

干预措施:

有胃肠道症状

干预措施代码:

Intervention:

Diarrhea

Intervention code:

组别:

无胃肠道症状脓毒症组

样本量:

20

Group:

Sepsis without Diarrhea

Sample size:

干预措施:

无胃肠道症状

干预措施代码:

Intervention:

without Diarrhea

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东省 

市(区县):

广州市 

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广东省中医院大学城医院 

单位级别:

三级甲等 

Institution
hospital:

Guangdong Provincial Hospital of Traditional Chinese Medicine,university city Branch

Level of the institution:

Tertiary A hospital

测量指标:

Outcomes:

指标中文名:

肠道菌群菌群16s测序

指标类型:

主要指标

Outcome:

16S?pyrosequencing

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血培养

指标类型:

主要指标

Outcome:

blood culture

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血常规

指标类型:

次要指标

Outcome:

blood routine examination

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

粪便

组织:

Sample Name:

feces

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

计算机产生的随机数字表

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number list generated by a computer

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

相关论文被杂志接受后(约2017年10月前)在临床试验公共管理平台ResMan上公布

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

the data will be published in the public management platform of clinical trials ResMan after related paper being accepted by journals(before October 2017 )

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

MRI和EEG数据保存在光盘里,纸质版由实验负责人保存;电子版采用EXCEL格式进行保存。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The MRI and EEG data stored in the compact disc, the paper version materials was preserved by experimental operator, and the electronic version records was saved by using EXCEL software.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

注册人:

Name of Registration:

 2016-03-22 20:30:56